We have excellent and exceptional technology in our compounds. For us to not run multiple programs would be not the right strategy. The potential GI market is likely to be significantly greater for CTIX then anti-biotics and we feel very confident with our product. During these months much research has gone into this. We very much want to enter the GI market. - Leo